The role of the p53 tumor suppressor gene in prostate cancer: A possible biomarker?
- 1 December 1996
- Vol. 48 (6) , 971-979
- https://doi.org/10.1016/s0090-4295(96)00365-2
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- GERMLINE p53 MUTATIONS AND HERITABLE CANCERAnnual Review of Genetics, 1994
- P53 Gene Alterations in Human Prostate CarcinomaJournal of Urology, 1993
- An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research TeamPublished by American Medical Association (AMA) ,1993
- Cancer statistics, 1993CA: A Cancer Journal for Clinicians, 1993
- P53 and Ki‐67 Immunoreactivity in Human Prostate Cancer and Benign HyperplasiaBritish Journal of Urology, 1992
- Comparative analysis ofp53 protein immunoreactivity in prostatic, lung and breast carcinomasVirchows Archiv, 1992
- p53, c-erbB-2 and the Epidermal Growth Factor Receptor in the Benign and Malignant ProstateJournal of Urology, 1992
- p53 Mutations in Human CancersScience, 1991
- Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndromeNature, 1990
- Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other NeoplasmsScience, 1990